Published in Parasitol Res on July 01, 1999
Recovery, bioaccumulation, and inactivation of human waterborne pathogens by the Chesapeake Bay nonnative oyster, Crassostrea ariakensis. Appl Environ Microbiol (2006) 1.18
Human waterborne parasites in zebra mussels ( Dreissena polymorpha) from the Shannon River drainage area, Ireland. Parasitol Res (2004) 1.15
Surface properties of Toxoplasma gondii oocysts and surrogate microspheres. Appl Environ Microbiol (2008) 1.00
Detection of infectious Cryptosporidium parvum oocysts in mussels (Mytilus galloprovincialis) and cockles (Cerastoderma edule). Appl Environ Microbiol (2000) 0.86
Quantitative assessment of viable Cryptosporidium parvum load in commercial oysters (Crassostrea virginica) in the Chesapeake Bay. Parasitol Res (2006) 0.83
Genotyping of Cryptosporidium isolates from Chamelea gallina clams in Italy. Appl Environ Microbiol (2004) 0.81
Molecular epidemiology of Cryptosporidium spp. and Giardia spp. in mussels (Mytilus californianus) and California sea lions (Zalophus californianus) from Central California. Appl Environ Microbiol (2014) 0.75
The development and implementation of a method using blue mussels (Mytilus spp.) as biosentinels of Cryptosporidium spp. and Toxoplasma gondii contamination in marine aquatic environments. Parasitol Res (2015) 0.75
Phylogenetic analysis of Cryptosporidium parasites based on the small-subunit rRNA gene locus. Appl Environ Microbiol (1999) 5.57
Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev (1986) 5.54
On standard definitions: 33 years hence. Arch Dermatol (1997) 4.32
Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl Environ Microbiol (1999) 4.22
The highly effective use of topical zinc pyrithione in the treatment of psoriasis: a case report. Dermatol Online J (1997) 2.68
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
Variation in Cryptosporidium: towards a taxonomic revision of the genus. Int J Parasitol (1999) 2.07
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology (1990) 1.94
Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. Proc Natl Acad Sci U S A (1987) 1.81
The role of non-biting flies in the epidemiology of human infectious diseases. Microbes Infect (2001) 1.74
Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons. J Infect Dis (1986) 1.70
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
The effects of reducing conditions, medium, pH, temperature, and time on in vitro excystation of Cryptosporidium. J Protozool (1984) 1.66
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Cryptosporidium systematics and implications for public health. Parasitol Today (2000) 1.66
Survival data for patients undergoing chronic intermittent hemodialysis. Ann Intern Med (1969) 1.58
Molecular and phylogenetic characterisation of Cryptosporidium from birds. Int J Parasitol (2001) 1.55
Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs. Am J Kidney Dis (1989) 1.55
Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int (2001) 1.52
Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (2000) 1.50
Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum. Infect Immun (1990) 1.50
Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis (1990) 1.49
Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med (1980) 1.47
Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol (1987) 1.44
Giardia sp. cysts and infectious Cryptosporidium parvum oocysts in the feces of migratory Canada geese (Branta canadensis). Appl Environ Microbiol (1998) 1.43
Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum. Infect Immun (1991) 1.43
Fish-oil-containing diet and platelet aggregation. Nutrition (1993) 1.42
Evaluation of commercial enzyme immunoassay (EIA) and immunofluorescent antibody (FA) test kits for detection of Cryptosporidium oocysts of species other than Cryptosporidium parvum. Am J Trop Med Hyg (1996) 1.42
Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. J Biol Chem (1983) 1.37
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis (1999) 1.37
Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest (1970) 1.35
Prevalence of Cryptosporidium, Giardia and Eimeria infections in post-weaned and adult cattle on three Maryland farms. Vet Parasitol (2000) 1.34
Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant (1998) 1.34
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. N Engl J Med (1970) 1.33
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis (1999) 1.33
Real-time PCR for the detection of Cryptosporidium parvum. J Microbiol Methods (2001) 1.32
Recovery of waterborne oocysts of Cryptosporidium from water samples by the membrane-filter dissolution method. Parasitol Res (1997) 1.28
The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol (1988) 1.27
Survival of infectious Cryptosporidium parvum oocysts in seawater and eastern oysters (Crassostrea virginica) in the Chesapeake Bay. Appl Environ Microbiol (1998) 1.27
An immunopathologic study of rapidly progressive glomerulonephritis in the adult. Hum Pathol (1971) 1.27
Development of first-generation schizonts of Eimeria bovis in cultured bovine cells. J Protozool (1967) 1.26
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) (1978) 1.25
Experimentally induced sarcocystis infection in calves: pathology. Am J Vet Res (1975) 1.25
Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med (1974) 1.24
Chronic autologous immune complex glomerulopathy: effect of cyproheptadine. J Lab Clin Med (1974) 1.24
Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites. Clin Microbiol Rev (1996) 1.24
IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol (1996) 1.23
Zoonotic transmission of Cryptosporidium parvum: Implications for water-borne cryptosporidiosis. Parasitol Today (1997) 1.23
Infectivity of Cryptosporidium parvum oocysts stored in water at environmental temperatures. J Parasitol (1998) 1.22
Phylogenetic relationships among isolates of Cryptosporidium: evidence for several new species. J Parasitol (1999) 1.22
Potential Role of the Eastern Oyster, Crassostrea virginica, in the Epidemiology of Cryptosporidium parvum. Appl Environ Microbiol (1997) 1.21
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int (1996) 1.20
Cryptosporidium canis n. sp. from domestic dogs. J Parasitol (2001) 1.20
Experimental glomerulonephritis in the guinea pig. I. Glomerular lesions associated with antiglomerular basement membrane antibody deposits. Lab Invest (1973) 1.16
Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae) oocyst and sporozoite antigens recognized by bovine colostral antibodies. Infect Immun (1990) 1.13
The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group. Am J Kidney Dis (1995) 1.12
Species and strain-specific typing of Cryptosporidium parasites in clinical and environmental samples. Mem Inst Oswaldo Cruz (1999) 1.12
Phylogenetic analysis of Cryptosporidium isolates from captive reptiles using 18S rDNA sequence data and random amplified polymorphic DNA analysis. J Parasitol (1999) 1.12
Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis (1994) 1.11
An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group. Diabetes Care (1996) 1.10
Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol (1987) 1.10
Experimental Sarcocystis hominis infection in cattle: lesions and ultrastructure of sarcocysts. J Parasitol (1988) 1.10
Recovery of waterborne Cryptosporidium parvum oocysts by freshwater benthic clams (Corbicula fluminea). Appl Environ Microbiol (1998) 1.09
Infectivity of Cryptosporidium parvum oocysts is retained upon intestinal passage through a migratory water-fowl species (Canada goose, Branta canadensis). Trop Med Int Health (1997) 1.09
Cloning and expression of a cDNA encoding epitopes shared by 15- and 60-kilodalton proteins of Cryptosporidium parvum sporozoites. Infect Immun (1993) 1.08
Focal segmental glomerular sclerosis: the cellular lesion. Kidney Int (1985) 1.07
A homeodomain protein selectively expressed in noradrenergic tissue regulates transcription of neurotransmitter biosynthetic genes. J Neurosci (1995) 1.07
Trans-synaptic increase in RNA coding for tyrosine hydroxylase in a rat sympathetic ganglion. Brain Res (1985) 1.07
Cryptosporidiosis: Pathogenesis and immunology. Parasitol Today (1992) 1.07
A redescription of Cryptosporidium galli Pavlasek, 1999 (Apicomplexa: Cryptosporidiidae) from birds. J Parasitol (2003) 1.06
Oyster herpes-type virus. Science (1972) 1.06
Cryptosporidium meleagridis in an Indian ring-necked parrot (Psittacula krameri). Aust Vet J (2000) 1.06
Immunotactoid glomerulopathy. Medicine (Baltimore) (1985) 1.06
Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice. Vaccine (1999) 1.05
Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch Intern Med (1987) 1.04
Identification of antinative DNA antibodies in cryoglobulinemic states. Am J Med (1978) 1.04
House flies (Musca domestica) as transport hosts of Cryptosporidium parvum. Am J Trop Med Hyg (1999) 1.04
Rotifers ingest oocysts of Cryptosporidium parvum. J Eukaryot Microbiol (2000) 1.03
Seroepidemiologic study of Cryptosporidium infection in children from rural communities of Anhui, China and Fortaleza, Brazil. Am J Trop Med Hyg (1994) 1.03
Accessory nipples and associated conditions. Pediatr Dermatol (1997) 1.03
Circulating immune complex assays in patients with lupus and membranous glomerulonephritis. Clin Immunol Immunopathol (1979) 1.02
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis (1999) 1.02
Effect of nutritional iron deficiency on acute and chronic inflammation. Ann Rheum Dis (1987) 1.02
Comparison of tests for viable and infectious Cryptosporidium parvum oocysts. Parasitol Res (2002) 1.02
Susceptibility of the Chesapeake Bay to environmental contamination with Cryptosporidium parvum. Environ Res (2000) 1.01
Gaseous disinfection of Cryptosporidium parvum oocysts. Appl Environ Microbiol (1996) 1.01